Sales of injectable anti-HIV therapeutics will reach $2 billion in 2029: GlobalData EP News Bureau Feb 27, 2021 Cabotegravir-based therapies are projected to generate 79 per cent of the sales of injectable therapeutics in the HIV market in…
